Excellent Biochemical Response to Polychemotherapy with Nab-Paclitaxel/Gemcitabine in an 82-Year-Old Female with Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1662-6575|7|3|638-642

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.3, 2014-09, pp. : 638-642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 687-692

Karger

Access to resources Recommend Favorite

A Near-Complete Response to Treatment with Gemcitabine plus nab®-Paclitaxel in a Patient with Metastatic Pancreatic Cancer and Poor Performance Status: A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-10 ,pp. : 711-717

Karger

Access to resources Recommend Favorite

Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic, Triple-Negative, BRCA1-Positive Breast Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-04 ,pp. : 252-259

Karger

Access to resources Recommend Favorite

Complete and Sustained Response with a Doublet Chemotherapy Protocol in an 81-Year-Old Patient with Metastatic Breast Cancer

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-10 ,pp. : 580-585

Karger

Access to resources Recommend Favorite

Gemcitabine Plus Nab-Paclitaxel as Second-Line and Beyond Treatment for Metastatic Pancreatic Cancer: a Single Institution Retrospective Analysis

By  

Reviews on Recent Clinical Trials, Vol. 10, Iss. 2, 2015-01 ,pp. : 142-145

Bentham Science Publishers

Access to resources Recommend Favorite